| Bioactivity | Neuropeptide W-23 (human) (NPW-23), the active form of Neuropeptide W, is an endogenous agonist of NPBW1 (GPR7) and NPBW2 (GPR8)[1]. | ||||||
| Invitro | Neuropeptide W-23 (human) (NPW-23) increases the ICa,L in transfected human embryonic kidney 293 cells and VSMCs via GPR7[1]. Neuropeptide W-23 (human) increases the expression of pan phospho-PKC, intracellular diacylglycerol level, and the second messenger catalyzed by PLC[1]. | ||||||
| Name | Neuropeptide W-23 (human) | ||||||
| CAS | 383415-79-0 | ||||||
| Sequence | Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Met-Gly-Leu | ||||||
| Shortening | WYKHVASPRYHTVGRAAGLLMGL | ||||||
| Formula | C119H183N35O28S | ||||||
| Molar Mass | 2584.01 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
Neuropeptide W-23 (human)
CAS: 383415-79-0 F: C119H183N35O28S W: 2584.01
Neuropeptide W-23 (human) (NPW-23), the active form of Neuropeptide W, is an endogenous agonist of NPBW1 (GPR7) and NPBW
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.